SkyePharma Makes French Acquisition

29 September 1996

SkyePharma of the UK is to acquire a pharmaceutical manufacturing facility near Lyon, France from Wyeth-Ayerst, a subsidiary of American Home Products. The deal will be made through SkyePharma's principal operating subsidiary Jago.

Under the terms of the agreement, Jago will acquire a newly-incorporated subsidiary of Wyeth into which a 66,000 square meter site at L'Isle D'Abeau, outside Lyon, will have been transferred for a consideration of 1 French franc, according to SkyePharma.

The site comprises a plant and laboratories providing 17,000 square meters of floor space together with an adjoining administration building covering 2,400 square meters.

This article is accessible to registered users, to continue reading please register for free.  A free trial will give you access to exclusive features, interviews, round-ups and commentary from the sharpest minds in the pharmaceutical and biotechnology space for a week. If you are already a registered user please login. If your trial has come to an end, you can subscribe here.

Login to your account

Become a subscriber

 

£820

Or £77 per month

Subscribe Now
  • Unfettered access to industry-leading news, commentary and analysis in pharma and biotech.
  • Updates from clinical trials, conferences, M&A, licensing, financing, regulation, patents & legal, executive appointments, commercial strategy and financial results.
  • Daily roundup of key events in pharma and biotech.
  • Monthly in-depth briefings on Boardroom appointments and M&A news.
  • Choose from a cost-effective annual package or a flexible monthly subscription
The Pharma Letter is an extremely useful and valuable Life Sciences service that brings together a daily update on performance people and products. It’s part of the key information for keeping me informed

Chairman, Sanofi Aventis UK



Companies featured in this story

More ones to watch >


Today's issue

Company Spotlight